Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Yonglan Zhou"'
Qiliqiangxin Protects Against Cardiac Ischemia-Reperfusion Injury via Activation of the mTOR Pathway
Publikováno v:
Cellular Physiology and Biochemistry, Vol 37, Iss 2, Pp 454-464 (2015)
Background/Aims: Qiliqiangxin (QL) has been used for the treatment of chronic heart failure in China. Accumulating evidence suggests QL's cardio-protective effects on continuous myocardial ischemia. However, it is unclear whether QL has beneficial ef
Externí odkaz:
https://doaj.org/article/7b4da75a26c542929aa3d7dc6acc45c3
Qiliqiangxin Protects Against Cardiac Ischemia-Reperfusion Injury via Activation of the mTOR Pathway
Publikováno v:
Cellular Physiology and Biochemistry, Vol 37, Iss 2, Pp 454-464 (2015)
Background/Aims: Qiliqiangxin (QL) has been used for the treatment of chronic heart failure in China. Accumulating evidence suggests QL's cardio-protective effects on continuous myocardial ischemia. However, it is unclear whether QL has beneficial ef
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::259d51ef8c8345d3e01ac992070b6b13
https://pubmed.ncbi.nlm.nih.gov/26315320
https://pubmed.ncbi.nlm.nih.gov/26315320
Autor:
Xiangqing Kong, Anthony Rosenzweig, Siyi Fu, Saumya Das, Yonglan Zhou, Hongyi Fang, Lichan Tao, Sutong Shen, Xinli Li, Joost P.G. Sluijter, Junjie Xiao, Xiuzhi Wang
Publikováno v:
Scientific Reports
Scientific Reports, 5. Nature Publishing Group
Scientific Reports, 5. Nature Publishing Group
In a multicenter randomized double-blind study we demonstrated that Qiliqiangxin (QLQX), a traditional Chinese medicine, had a protective effect in heart failure patients. However, whether and via which mechanism QLQX attenuates cardiac remodeling af
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a493bf139df06c15e28b661f6f667f8
https://pubmed.ncbi.nlm.nih.gov/25669146
https://pubmed.ncbi.nlm.nih.gov/25669146